Lestaurtinib and its Impurities

Lestaurtinib has undergone clinical trials for the treatment of various cancers, including pancreatic and prostate cancers, V617F JAK2 positive polycythemia vera and essential thrombocytosis, and refractory neuroblastoma. Reference standards of Lestaurtinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.